As of 28 Aug 2026, Hester Biosciences Ltd share price is ₹2,299.00. The stock opened at ₹2,299.00 and had closed at ₹2,353.30 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹1,250.95 and a high of ₹2,669.00. In terms of performance, Hester Biosciences Ltd share price has increased by 49.18% over the past six months and has increased by 13.51% over the last year.
HESTERBIO Charts
Hester Biosciences Ltd Overview
About HESTERBIO
Hester Biosciences is principally engaged in manufacturing of veterinary vaccines and trading of veterinary health products.
Hester Biosciences Ltd Historical Performance
Hester Biosciences Ltd Fundamental Analysis
Hester Biosciences Ltd Financials
| Indicator | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 |
|---|---|---|---|---|---|
| Revenue | 74.34 | 97.89 | 71.39 | 66.06 | 64.44 |
| EBITDA | 26.03 | 42.64 | 17.75 | 13.35 | 13.36 |
| Net Profit | 14.71 | 26.38 | 10.67 | 7.21 | 7.84 |
| EPS | 17.29 | 31.01 | 12.54 | 8.48 | 9.21 |
Hester Biosciences Ltd Technical Analysis
| Indicator | Value |
|---|---|
| RSI | 45.48 |
| MACD | 7.38 |
| 20-Day SMA | 2,432.54 |
Hester Biosciences Ltd Corporate Actions
| Corporate Action | Ex Date | Record Date |
|---|---|---|
| No forthcoming board meetings available. | ||
Hester Biosciences Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,913.30+0.73% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,060.00+0.39% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,999.00+2.23% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Hester Biosciences Ltd today is ₹2,299.00 on NSE and ₹2,299.00 on BSE.
- The 52-week high of Hester Biosciences Ltd is ₹2,669.00, while the 52-week low is ₹1,250.95.
- The current market capitalisation of Hester Biosciences Ltd is approximately ₹2,002 crore.
- The P/E (Price-to-Earnings) ratio of Hester Biosciences Ltd is 30.07. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Hester Biosciences Ltd is 3.78. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To invest in Hester Biosciences Ltd shares,
• Open a Demat and trading account with a registered broker
• Add funds to your account
• Search for Hester Biosciences Ltd on the trading platform
• Place a buy order
• Track your investments - Over the past 3 years, Hester Biosciences Ltd has delivered a return of approximately 34.27%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Hester Biosciences Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 53.73% promoters, 0.31% FIIs, 0.00% DIIs, and 33.00% public shareholders.
